Hoffman v. Sterling Drug, Inc.

Decision Date19 April 1974
Docket NumberCiv. No. 68-391.
Citation374 F. Supp. 850
PartiesClifton F. HOFFMAN v. STERLING DRUG, INC. and Winthrop Laboratories, Inc.
CourtU.S. District Court — Middle District of Pennsylvania

COPYRIGHT MATERIAL OMITTED

Joseph D. Shein, Shein & Brookman, P. A., Philadelphia, Pa., William B. Anstine, Jr., Anstine & Anstine, York, Pa., for plaintiff.

Bernard J. Smolens, Joseph A. Tate, Schnader, Harrison, Segal & Lewis, Philadelphia, Pa., for defendants.

MEMORANDUM OPINION AND ORDER

HERMAN, District Judge.

This case arises out of a products liability claim brought by the plaintiff seeking compensation for the blindness the defendants' drug Aralen allegedly caused him. A very lengthy trial was conducted which resulted in a jury verdict for the plaintiff in the sum of $437,000. This court denied the defendants' motion for a new trial and the plaintiff's motion for a re-trial on the issue of punitive damages. On cross appeals the circuit reversed and remanded for a new trial on the issues of compensatory and punitive damages. Hoffman v. Sterling Drug, Inc., 485 F.2d 132 (3d Cir. 1973).

On remand oral argument was had and briefs submitted on numerous crucial and controlling issues which require resolution before the parties undergo a second prolonged trial. The court also heard argument on the question of whether the issues at hand should be certified as controlling questions of law pursuant to 28 U.S.C. § 1292(b) and thereby submitted to the Court of Appeals for pre-trial resolution.

INFLATION AND FUTURE EARNINGS

At the original trial this court allowed the plaintiff's actuary/economist to testify as to the estimated loss of future earnings for the plaintiff, an architectural draftsman. The percentage used by the economist was based upon the testimony of two area architects who estimated that salaries of individuals engaged in work comparable to that of plaintiff, had, over the previous five years, increased between 6 and 10% per annum. Based on those two annual percentage increases and the plaintiff's 26-year life expectancy, the economist computed two lifetime earning figures and reduced each to present worth. It was this testimony which the Court of Appeals ruled to have been improperly admitted into evidence. The present conflict between the parties finds them completely at odds on the issue of future economic trends. The plaintiff contends that the circuit found error in our admitting the testimony based on such a brief span of time. Plaintiff's counsel has indicated that he is prepared to supply a 20-year history of economic trends to satisfy what he sees as the rule of this circuit. The defendants have countered by asking this court to prohibit all evidence of future inflationary and economic trends.

The resolution of the matter is rendered more complex due to an imprecision of terms. Frequently the expressions "earnings increase factor" and "economic trends" (inflation/deflation) are used interchangeably by the courts. The distinction, as this court views it, is that the former constitutes merit raises predicted over the plaintiff's life expectancy, while the latter reflects economic trends separate from any individual's employment situation.

The testimony at issue, whatever its label, involves regular annual increases based on general economic conditions (primarily inflation) as the circuit noted in Hoffman:

"Although offered in terms of continuing increases in wage rates, as opposed to a continuing decline in the value of the dollar, the testimony in question reflects a continuing inflationary spiral. . . ." 485 F.2d, at 143.

If this court concludes that future economic trends are a permissible part of future earnings we must first determine how such trends are to be proved. One method, in effect, averages the rate of inflation/deflation over a substantial period from the past, then extrapolates that annual average over the plaintiff's life expectancy. The other requires a projection into the future economic trends not necessarily controlled by past indicators.

In Hoffman the circuit said: "We note that inflationary considerations have been almost universally rejected as a factor in computing future losses." 485 F.2d, at 143-144.

It bears note that the circuit cited Sleeman v. Chesapeake and Ohio Ry. Co., 414 F.2d 305 (6th Cir. 1969) for the proposition that future inflation is speculative per se. It was the Sleeman court which aptly described the quagmire:

"The inflation versus deflation debate rages inconclusively at the highest policy levels of our government, in national electoral campaigns, in learned economic journals and is exemplified in the daily gyrations of the stock markets. The debate seems unlikely to be resolved satisfactorily in one personal injury trial. And if testimonial resolution of this factor bearing on the future is attempted, the door is opened to similarly speculative and debatable offsets tending in other directions."2

Immediately thereafter the Hoffman court found Magill v. Westinghouse Electric Corp., 464 F.2d 294 (3d Cir. 1972) to be controlling:

"Similarly in the case at bar, we do not think there was a substantial factual basis for the assumption that salaries of architectural draftsmen in the York area would increase at 6% per year for the next 26 years. Both the present case and Magill are marked by the total absence of any evidence of probable future salary or economic trends. . . . In short, the projected 6% per year earnings increase in the present case is speculation, requiring a new trial on the question of damages." 485 F.2d, at 144.

Plaintiff's counsel attempts to use cases and arguments supportive of projected future incomes in support of his contention that future economic trends affecting that income are similarly admissible.

In this court's view the plaintiff misreads the Hoffman decision's reliance on Magill. The circuit found Magill to govern as a result of this court's refusal to allow the plaintiff's economist to project his opinion on the declining value of the dollar, thus leaving the sole issue of an earnings increase factor for consideration by the jury.

"No evidence was introduced in the case at bar as to the probability or magnitude of future inflationary trends and there was no evidence projecting inflation over a long period of time. . . .
* * * * * *
"The propriety of Schoenwald's the plaintiff's actuary/economist use of the 6% `earnings increase factor' is thereby governed by our recent decision in Magill." 485 F.2d, at 144.

This court's error in the original trial was not our refusal to allow evidence on future economic trends, but rather our admission into the record of an earnings increase factor based on insufficient evidence. A close reading of Magill bears this out. Judge Adams' opinion in Magill carefully distinguishes between future earning power and future inflation. Quoting from Pilipovich v. Pittsburgh Coal Co., 314 Pa. 585, 172 A. 136 (1934), the court made clear that future earning power is determined by looking to the plaintiff's peculiar individual abilities:

"`It is the duty of the plaintiff to show the earning power of the deceased, or give such evidence in regard to his business, business habits, and past earnings, as may afford some basis from which earning capacity may be fairly estimated (Citation omitted) . . . The pecuniary loss is what the deceased would probably have earned by his labor, physical or intellectual, in his business or profession . . . In fixing this amount, consideration should be given to the age of the deceased, his health, his ability and disposition to labor, his habits of living, and his expenditures.'" 464 F.2d, at 300.

Drawing on the Pilipovich ruling, the Magill court thereafter concluded that "had the administrator introduced well-founded evidence that Mr. Magill would have received certain promotions or pay raises in the future, such evidence might not have been objectionable. However, the Pennsylvania Supreme Court `has held repeatedly that a claim for damages must be supported by a reasonable basis for calculation; mere guess or speculation is not enough.'" (Id.)

At the original trial of the instant case the plaintiff introduced testimony regarding architects' salaries generally rising between 6 and 10% annually. Such testimony is no more than a backhanded mode of injecting inflation into future earnings and is directly contra to the Pilipovich holding that future earnings must be tailored to the particular plaintiff. As if to dispel any doubt the Magill court allowed that:

"Because there may be a substantial factual basis for use of an earnings increase factor, we do not foreclose the administrator from attempting, at the new trial, to establish that foundation. . . . We note, however, that the concepts of inflation and the declining value of the dollar have been almost universally rejected as providing support for the earnings increase factor." 464 F.2d, at 301. (Emphasis supplied)

The Hoffman court also relied upon Frankel v. United States, 321 F.Supp. 1331 (E.D.Pa.1970), aff'd, 466 F.2d 1226 (3d Cir. 1972). The trial court in Frankel refused to admit evidence that the cost of institutional care was increasing due to inflation. Chief Judge Sheridan of the Middle District (sitting by designation), declared:

"Economists differ on their predictions. Moreover, plaintiff will have money that can be invested and if inflation continues, the return on the money will be greater, and this would have an offsetting effect." 321 F. Supp., at 1346.

Taken together, this court does not read Magill and Frankel as being equivocal on the issue of economic trends in computing loss of future earnings. The Hoffman decision prefaced its discussion of this issue by citing Russell v. City of Wildwood, 428 F.2d 1176 (3d Cir. 1970) for the proposition that "reasonable certainty" is needed in computing future earnings despite the "host of uncertain contingencies." 485 F.2d at 143.

Harper & James, cited with...

To continue reading

Request your trial
12 cases
  • Soldo v. Sandoz Pharmaceuticals Corp.
    • United States
    • U.S. District Court — Western District of Pennsylvania
    • January 13, 2003
    ...human effects," the court rejected this type of analysis and excluded the testimony under Rule 702. Id. 92. In Hoffman v. Sterling Drug, Inc., 374 F.Supp. 850 (M.D.Pa.1974), a retrial of a product liability action regarding the drug Aralen, the plaintiff sought to introduce evidence of "che......
  • Huddell v. Levin
    • United States
    • U.S. District Court — District of New Jersey
    • May 28, 1975
    ...are cited in support of this proposition. Hoffman v. Sterling Drug, Inc., 485 F.2d 132 (3d Cir. 1973) (2-1 decision), on remand, 374 F.Supp. 850 (M.D.Pa.1974); Magill v. Westinghouse Elec. Corp., 464 F.2d 294 (3d Cir. 1972). In both cases, the court held that the "expert" testimony offered ......
  • Martin v. Johns-Manville Corp.
    • United States
    • Pennsylvania Supreme Court
    • June 28, 1985
    ...621 (Alaska 1980) (original punitive damages award of $2,895,000 reduced to $500,000 instead of $250,000); Hoffman v. Sterling Drug, Inc., 374 F.Supp. 850, 856-57 (M.D.Pa.1974), on remand from 485 F.2d 132 (3d Cir.1973) (applying Pennsylvania law); Toole v. Richardson-Merrell, Inc., 251 Cal......
  • Golod v. Hoffman La Roche
    • United States
    • U.S. District Court — Southern District of New York
    • May 20, 1997
    ...idiosyncratic side effect, question of whether warning as to either drug was adequate was for jury); but see Hoffman v. Sterling Drug, Inc., 374 F.Supp. 850, 862 (M.D.Pa.1974) (rejecting evidence of side effects of drug in same chemical family, on grounds probative value of such evidence wa......
  • Request a trial to view additional results
6 books & journal articles
  • Trial Proceedings and Motions
    • United States
    • James Publishing Practical Law Books Archive Trial Evidence Foundations - 2016 Contents
    • July 31, 2016
    ...of a jury that has been exposed to particular efforts to pre-dispose the result before trial begins. Hoffman v. Sterling Drug, Inc. , 374 F. Supp. 850 (M.D. Pa. 1974). A plaintiff in a diversity personal injury action has the right to propound questions to jurors on voir dire concerning the......
  • Trial Proceedings and Motions
    • United States
    • James Publishing Practical Law Books Trial Evidence Foundations Trial Proceedings and Motions
    • May 5, 2019
    ...of a jury that has been exposed to particular efforts to predispose the result before trial begins. Hoffman v. Sterling Drug, Inc. , 374 F. Supp. 850 (M.D. Pa. 1974). A plaintiff in a diversity personal injury action has the right to propound questions to jurors on voir dire concerning thei......
  • Trial proceedings and motions
    • United States
    • James Publishing Practical Law Books Archive Trial Evidence Foundations - 2017 Contents
    • July 31, 2017
    ...of a jury that has been exposed to particular e൵orts to predispose the result before trial begins. Hoৼman v. Sterling Drug, Inc. , 374 F. Supp. 850 (M.D. Pa. 1974). A plainti൵ in a diversity personal injury action has the right to propound questions to jurors on voir dire concerning their c......
  • Trial proceedings and motions
    • United States
    • James Publishing Practical Law Books Archive Trial Evidence Foundations - 2018 Contents
    • July 31, 2018
    ...of a jury that has been exposed to particular e൵orts to predispose the result before trial begins. Hoৼman v. Sterling Drug, Inc. , 374 F. Supp. 850 (M.D. Pa. 1974). A plainti൵ in a diversity personal injury action has the right to propound questions to jurors on voir dire concerning their c......
  • Request a trial to view additional results

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT